<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04840446</url>
  </required_header>
  <id_info>
    <org_study_id>PTL-904288</org_study_id>
    <nct_id>NCT04840446</nct_id>
  </id_info>
  <brief_title>Evaluation of Modified Adhesives With Dexcom G6 Sensor</brief_title>
  <official_title>Evaluation of Modified Adhesives With Dexcom G6 Sensor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DexCom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jaeb Center for Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DexCom, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to collect and compare information on the performance of CGM&#xD;
      adhesives in adults.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Actual">March 19, 2021</completion_date>
  <primary_completion_date type="Actual">March 16, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adhesiveness and survivability of the adhesives</measure>
    <time_frame>10-days</time_frame>
    <description>Number of adhesives that survive on the body during wear period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin irritation with the adhesives</measure>
    <time_frame>10-days</time_frame>
    <description>Proportion of participants who self-report skin irritation during wear period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse events with the adhesives</measure>
    <time_frame>10-days</time_frame>
    <description>Highest Draize scale score for adhesive erythema, and edema during wear period. Recorded medical adhesive-related skin injuries (MARSI) and severity during wear period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess user preference or acceptance of the adhesives worn during the study</measure>
    <time_frame>10-days</time_frame>
    <description>Final day post-study satisfaction questionnaire (for each adhesive) will be given a score by taking the mean response on the scale 1-5. Satisfaction scores will be tabulated by adhesive.</description>
  </secondary_outcome>
  <enrollment type="Actual">80</enrollment>
  <condition>Diabetes</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dexcom Continuous Glucose Monitoring System</intervention_name>
    <description>Dexcom Sensor</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Potential study participants will be identified via diabetes patient website and/or virtual&#xD;
        registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 or older;&#xD;
&#xD;
          2. No previously self-reported adhesive reactions to the any continuous glucose monitor&#xD;
             (CGM);&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Extensive skin changes/diseases that preclude wearing the required number of devices&#xD;
             (e.g., history of severe reactions from adhesive wear, extensive psoriasis, recent&#xD;
             burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos,&#xD;
             dermatitis herpetiformis) at the proposed wear sites;&#xD;
&#xD;
          2. Current or anticipated use of systemic corticosteroids (oral, injectable, or&#xD;
             intravenous)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas J Mouse, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jaeb Center for Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jaeb Center for Health Research</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33647</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Continuous Glucose Monitoring Systems</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

